Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAIO NYSE:INTT NASDAQ:KEQU NASDAQ:NAUT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAIOData I/O$3.33+0.6%$3.26$1.88▼$3.57$31.07M1.0521,592 shs15,103 shsINTTinTEST$8.24+5.8%$7.39$5.24▼$9.77$102.82M1.5838,260 shs62,029 shsKEQUKewaunee Scientific$43.14-1.6%$50.58$30.33▼$71.33$125.60M0.6814,327 shs13,953 shsNAUTNautilus Biotechnology$0.90-0.2%$0.74$0.62▼$3.03$113.95M1.48374,624 shs168,299 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAIOData I/O+1.22%-2.07%+3.44%+4.75%+36.78%INTTinTEST+4.07%+0.26%+8.19%+3.73%+11.13%KEQUKewaunee Scientific-0.16%-0.84%-20.02%-25.08%+34.49%NAUTNautilus Biotechnology+4.18%+8.02%+28.70%+19.97%-66.46%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAIOData I/O$3.33+0.6%$3.26$1.88▼$3.57$31.07M1.0521,592 shs15,103 shsINTTinTEST$8.24+5.8%$7.39$5.24▼$9.77$102.82M1.5838,260 shs62,029 shsKEQUKewaunee Scientific$43.14-1.6%$50.58$30.33▼$71.33$125.60M0.6814,327 shs13,953 shsNAUTNautilus Biotechnology$0.90-0.2%$0.74$0.62▼$3.03$113.95M1.48374,624 shs168,299 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAIOData I/O+1.22%-2.07%+3.44%+4.75%+36.78%INTTinTEST+4.07%+0.26%+8.19%+3.73%+11.13%KEQUKewaunee Scientific-0.16%-0.84%-20.02%-25.08%+34.49%NAUTNautilus Biotechnology+4.18%+8.02%+28.70%+19.97%-66.46%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAIOData I/O 2.00Hold$5.2256.76% UpsideINTTinTEST 2.50Moderate Buy$12.0045.63% UpsideKEQUKewaunee Scientific 2.00HoldN/AN/ANAUTNautilus Biotechnology 1.00Sell$2.13136.11% UpsideCurrent Analyst Ratings BreakdownLatest DAIO, KEQU, NAUT, and INTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025DAIOData I/OWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025KEQUKewaunee ScientificWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)10/8/2025NAUTNautilus BiotechnologyWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/6/2025INTTinTESTZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold9/27/2025DAIOData I/OWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025KEQUKewaunee ScientificWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)9/27/2025NAUTNautilus BiotechnologyWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/15/2025INTTinTESTLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$8.007/25/2025DAIOData I/OWestpark CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.22(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAIOData I/O$21.77M1.44N/AN/A$1.91 per share1.74INTTinTEST$121.64M0.85$1.43 per share5.75$7.92 per share1.04KEQUKewaunee Scientific$240.47M0.51$7.23 per share5.97$23.21 per share1.86NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAIOData I/O-$3.09M-$0.28N/A∞N/A-11.49%-14.60%-10.62%10/23/2025 (Estimated)INTTinTEST$9.34M-$0.0735.8320.60N/A2.33%5.31%3.42%N/AKEQUKewaunee Scientific$11.40M$4.1310.45∞N/A4.68%25.65%9.29%12/9/2025 (Estimated)NAUTNautilus Biotechnology-$70.78M-$0.52N/AN/AN/AN/A-32.53%-27.85%10/28/2025 (Estimated)Latest DAIO, KEQU, NAUT, and INTT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/10/2025Q1 2026KEQUKewaunee ScientificN/A$1.10N/A$1.04N/A$71.10 million7/31/2025Q2 2025NAUTNautilus Biotechnology-$0.14-$0.12+$0.02-$0.12N/AN/A7/24/2025Q2 2025DAIOData I/O-$0.05-$0.08-$0.03-$0.08$5.50 million$5.95 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDAIOData I/ON/AN/AN/AN/AN/AINTTinTESTN/AN/AN/AN/AN/AKEQUKewaunee ScientificN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAIOData I/ON/A4.062.89INTTinTEST0.082.261.38KEQUKewaunee Scientific0.882.321.63NAUTNautilus BiotechnologyN/A18.5218.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAIOData I/O36.95%INTTinTEST63.18%KEQUKewaunee Scientific32.69%NAUTNautilus Biotechnology50.71%Insider OwnershipCompanyInsider OwnershipDAIOData I/O2.60%INTTinTEST7.00%KEQUKewaunee Scientific13.30%NAUTNautilus Biotechnology41.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAIOData I/O1009.39 million9.14 millionOptionableINTTinTEST32012.48 million11.69 millionOptionableKEQUKewaunee Scientific1,2392.87 million2.49 millionNot OptionableNAUTNautilus Biotechnology130126.31 million74.39 millionOptionableDAIO, KEQU, NAUT, and INTT HeadlinesRecent News About These CompaniesNautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025October 7 at 10:52 AM | markets.businessinsider.comNautilus Biotechnology, Inc. to Announce Third Quarter 2025 Financial Results on October 28, 2025October 7 at 8:30 AM | quiverquant.comQNautilus Biotechnology (NASDAQ:NAUT) Trading Down 3.2% - Here's WhySeptember 30, 2025 | marketbeat.comNautilus Biotechnology’s Earnings Call: Progress Amid ChallengesSeptember 19, 2025 | theglobeandmail.comCEO's Major Investment Signals Confidence in Nautilus BiotechnologySeptember 17, 2025 | aktiencheck.deAPositive Signs As Multiple Insiders Buy Nautilus Biotechnology StockSeptember 12, 2025 | finance.yahoo.comInsider Buying: Nautilus Biotechnology (NASDAQ:NAUT) CEO Buys 83,500 Shares of StockSeptember 11, 2025 | marketbeat.comInsider Buying: Nautilus Biotechnology (NASDAQ:NAUT) CEO Acquires 116,500 Shares of StockSeptember 11, 2025 | marketbeat.comInsider Buying: Nautilus Biotechnology (NASDAQ:NAUT) CEO Purchases 83,500 Shares of StockSeptember 10, 2025 | insidertrades.comNautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comNautilus Biotechnology (NASDAQ:NAUT) General Counsel Matthew Murphy Buys 20,000 SharesSeptember 6, 2025 | insidertrades.comNew Partnership Will Probe the Connection Between Tau Protein and Alzheimer’sSeptember 4, 2025 | technologynetworks.comTNautilus Biotechnology to Participate in Upcoming September Investor ConferencesAugust 27, 2025 | globenewswire.comNautilus Biotechnology jumps after Amazon discloses $1M stakeAugust 5, 2025 | msn.comNautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call TranscriptAugust 1, 2025 | seekingalpha.comNautilus Biotechnology Reports Second Quarter 2025 Financial ResultsJuly 31, 2025 | globenewswire.comNautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule ProteomicsJuly 31, 2025 | tmcnet.comSeattle Tech Week 2025: What Makes Seattle the Next Great Tech Hub?July 19, 2025 | jdsupra.comNautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025July 15, 2025 | finance.yahoo.comNautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025July 15, 2025 | globenewswire.comNautilus Biotechnology Inc Ordinary Shares - MorningstarJuly 2, 2025 | morningstar.comMMedia Sentiment Over TimeDAIO, KEQU, NAUT, and INTT Company DescriptionsData I/O NASDAQ:DAIO$3.33 +0.02 (+0.60%) Closing price 03:57 PM EasternExtended Trading$3.32 -0.02 (-0.45%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. Its programming system products are used to program integrated circuits (ICs) with the specific data for the ICs. The company offers PSV handlers off-line automated programming systems, such as PSV2800 automated programming system which focuses on high-volume manufacturing in a lower cost platform; PSV7000 automated programming system for security deployment upgrades; PSV5000 automated programming system that combines mid-range capacity and supports security deployment; and PSV3500 automated programming system which provides basic programming needs. It also provides SentriX security deployment system; and LumenX and non-automated FlashPAK III programming systems. In addition, the company offers hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, internet of things, and industrial, as well as electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.inTEST NYSE:INTT$8.24 +0.45 (+5.78%) Closing price 04:00 PM EasternExtended Trading$8.31 +0.07 (+0.85%) As of 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Kewaunee Scientific NASDAQ:KEQU$43.14 -0.69 (-1.57%) Closing price 04:00 PM EasternExtended Trading$43.32 +0.18 (+0.42%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.Nautilus Biotechnology NASDAQ:NAUT$0.90 0.00 (-0.24%) Closing price 04:00 PM EasternExtended Trading$0.90 +0.00 (+0.44%) As of 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
